Next Article in Journal
Characterization of Graft Copolymers Synthesized from p-Aminosalicylate Functionalized Monomeric Choline Ionic Liquid
Previous Article in Journal
The Role of Five-Membered Heterocycles in the Molecular Structure of Antibacterial Drugs Used in Therapy
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Qamar et al. Treatment of Peripheral Artery Disease Using Injectable Biomaterials and Drug-Coated Balloons: Safety and Efficacy Perspective. Pharmaceutics 2023, 15, 1813

1
Bioengineering Research and Development Centre (BioIRC), Prvoslava Stojanovića 6, 34000 Kragujevac, Serbia
2
Faculty of Engineering, University of Kragujevac, Sestre Janjić 6, 34000 Kragujevac, Serbia
3
Institute for Information Technologies Kragujevac, University of Kragujevac, Jovana Cvijića бб, 34000 Kragujevac, Serbia
*
Author to whom correspondence should be addressed.
Pharmaceutics 2023, 15(11), 2555; https://doi.org/10.3390/pharmaceutics15112555
Submission received: 17 October 2023 / Accepted: 17 October 2023 / Published: 30 October 2023
(This article belongs to the Section Pharmacokinetics and Pharmacodynamics)
There was an error in the original publication [1] comprising a misstatement of the text regarding NanoPac. A correction has been made to:
-
Section 4, Subsection 4.1.1, through the removal of “One of the studies has shown that NanoPac is responsible for inducing tumor in an in vivo model [37], while another study has provided the detail on its pharmacokinetics profile [38] and ability to reduce tumor regression [39]” and the removal of references 37, 38, and 39;
-
Table 2, Column “Outcome”, through the removal of “lower percentage area stenosis; improved neointimal proliferation and reduced tumor regression” and the addition of “more studies needed to be carried out for assessing the actual potential”.
With these corrections, the order of some references have been adjusted accordingly. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Qamar, S.U.R.; Spahić, L.; Benolić, L.; Zivanovic, M.; Filipović, N. Treatment of Peripheral Artery Disease Using Injectable Biomaterials and Drug-Coated Balloons: Safety and Efficacy Perspective. Pharmaceutics 2023, 15, 1813. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Qamar, S.U.R.; Spahić, L.; Benolić, L.; Zivanovic, M.; Filipović, N. Correction: Qamar et al. Treatment of Peripheral Artery Disease Using Injectable Biomaterials and Drug-Coated Balloons: Safety and Efficacy Perspective. Pharmaceutics 2023, 15, 1813. Pharmaceutics 2023, 15, 2555. https://doi.org/10.3390/pharmaceutics15112555

AMA Style

Qamar SUR, Spahić L, Benolić L, Zivanovic M, Filipović N. Correction: Qamar et al. Treatment of Peripheral Artery Disease Using Injectable Biomaterials and Drug-Coated Balloons: Safety and Efficacy Perspective. Pharmaceutics 2023, 15, 1813. Pharmaceutics. 2023; 15(11):2555. https://doi.org/10.3390/pharmaceutics15112555

Chicago/Turabian Style

Qamar, Safi Ur Rehman, Lemana Spahić, Leo Benolić, Marko Zivanovic, and Nenad Filipović. 2023. "Correction: Qamar et al. Treatment of Peripheral Artery Disease Using Injectable Biomaterials and Drug-Coated Balloons: Safety and Efficacy Perspective. Pharmaceutics 2023, 15, 1813" Pharmaceutics 15, no. 11: 2555. https://doi.org/10.3390/pharmaceutics15112555

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop